Dec 20, 2024· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2020-D-1530-0042
Comments from CHPA
FDANonrulemakingFDA-2020-D-1530
Control of Nitrosamine Impurities in Human Drugs; Guidance for Industry; Availability
RIN
—
Last modified
May 20, 2025
Comment window
—
Consumer Healthcare Products Association filings
2
Activity
Consumer Healthcare Products Association filed 2 comments on this docket between Dec 23, 2020 and Dec 20, 2024. 1 other organizations filed here.
What Consumer Healthcare Products Association filed (2)
Dec 23, 2020· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2020-D-1530-0016
Filed on regulations.gov — full text not in the inline record.
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (1)
See everyone who commented →- Consumer Healthcare Products AssociationTHIS ORG2 filings · confidence 97%
- Association for Accessible Medicinestrade assoc.3 filings · confidence 97%